Literature DB >> 25019294

WITHDRAWN: Dipyrone for acute primary headaches.

Adriana S Ramacciotti1, Bernardo G O Soares, Alvaro N Atallah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25019294      PMCID： PMC6464613          DOI： 10.1002/14651858.CD004842.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN： 1361-6137


× No keyword cloud information.
  25 in total

1.  Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis.

Authors:  M Bäckström; S Hägg; T Mjörndal; R Dahlqvist
Journal:  Pharmacoepidemiol Drug Saf       Date:  2002 Apr-May       Impact factor: 2.890

2.  Graphic representation of pain.

Authors:  J Scott; E C Huskisson
Journal:  Pain       Date:  1976-06       Impact factor: 6.961

Review 3.  Burden of migraine. A review of its socioeconomic impact.

Authors:  G D Solomon; K L Price
Journal:  Pharmacoeconomics       Date:  1997       Impact factor: 4.981

4.  Efficacy and safety of metamizol vs. acetylsalicylic acid in patients with moderate episodic tension-type headache: a randomized, double-blind, placebo- and active-controlled, multicentre study.

Authors:  P Martínez-Martín; E Raffaelli; F Titus; J Despuig; Y D Fragoso; E Díez-Tejedor; H Liaño; R Leira; M E Cornet; B S van Toor; J Cámara; H Peil; J M Vix; P Ortiz
Journal:  Cephalalgia       Date:  2001-06       Impact factor: 6.292

Review 5.  Single-dose dipyrone for acute postoperative pain.

Authors:  J E Edwards; F Meseguer; C C Faura; R A Moore; H J McQuay
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 6.  The burden of migraine. A review of cost to society.

Authors:  R B Lipton; W F Stewart; M Von Korff
Journal:  Pharmacoeconomics       Date:  1994-09       Impact factor: 4.981

Review 7.  [Metamizol--a new effective analgesic with a long history. Overview of its pharmacology and clinical use].

Authors:  Z Fendrich
Journal:  Cas Lek Cesk       Date:  2000-07-19

8.  Intravenous metamizol (Dipyrone) in acute migraine treatment and in episodic tension-type headache--a placebo-controlled study.

Authors:  M E Bigal; C A Bordini; J G Speciali
Journal:  Cephalalgia       Date:  2001-03       Impact factor: 6.292

9.  [Efficacy of three drugs in the treatment of migrainous aura: a randomized placebo-controlled study].

Authors:  Marcelo E Bigal; Carlos A Bordini; José Geraldo Speciali
Journal:  Arq Neuropsiquiatr       Date:  2002-06       Impact factor: 1.420

10.  Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: a randomized, double blind, placebo controlled study.

Authors:  Marcelo E Bigal; Carlos A Bordini; Stewart J Tepper; José G Speciali
Journal:  Headache       Date:  2002-10       Impact factor: 5.887
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.